H 581

 BILL AS INTRODUCED  H.581
 2026  Page 1 of 3
1H.581
2 Introduced by Representative Burrows of West Windsor
3 Referred to Committee on
4 Date:
5 Subject: Health; prescription drugs; Vermont Prescription Monitoring System;
6reproductive health care services; gender-affirming health care
7services
8 Statement of purpose of bill as introduced: This bill proposes not to require
9 the reporting of controlled substances prescribed for reproductive or gender-
10 affirming care to the Vermont Prescription Monitoring System unless the
11 Commissioner of Health determines that reporting is necessary to protect the
12 public health. The bill would also require that any information about those
13 medications that is in the Vermont Prescription Monitoring System be
14 excluded from sharing with other states’ prescription monitoring systems.
15    An act relating to limiting the reporting of certain medications to the
16    Vermont Prescription Monitoring System
17 It is hereby enacted by the General Assembly of the State of Vermont:
18 Sec. 1. 18 V.S.A. § 4283 is amended to read:
19 § 4283. CREATION; IMPLEMENTATION
                                                                    VT LEG #386242 v.1
 BILL AS INTRODUCED  H.581
 2026  Page 2 of 3
1    (a) The Department shall maintain an electronic database and reporting
2 system for monitoring Schedules II, III, and IV controlled substances, as
3 defined in 21 C.F.R. Part 1308, as amended and as may be amended, that are
4 dispensed within the State of Vermont by a health care provider or dispenser or
5 dispensed to an address within the State by a pharmacy licensed by the
6 Vermont Board of Pharmacy.
7    (b) As required by the Department, every dispenser who is licensed by the
8 Vermont Board of Pharmacy shall report to the Department in a timely manner
9 data for each controlled substance in Schedules II, III, and IV, as amended and
10 as may be amended, dispensed to a patient within Vermont. Reporting shall
11 not be required for:
12(1) a drug administered directly to a patient; or
13(2) a drug dispensed by a health care provider at a facility licensed by
14 the Department, provided that the quantity dispensed is limited to an amount
15 adequate to treat the patient for a maximum of 48 hours; or
16(3) a medication prescribed for purposes of reproductive health care
17 services or gender-affirming health care services, as those terms are defined in
18 1 V.S.A. § 150, unless the Commissioner determines that the reporting of those
19 medications is necessary to protect the public health.
20***
                                                                   VT LEG #386242 v.1
 BILL AS INTRODUCED  H.581
 2026  Page 3 of 3
1 Sec. 2. 18 V.S.A. § 4288 is amended to read:
2 § 4288. RECIPROCAL AGREEMENTS
3    The Department of Health may enter into reciprocal agreements with other
4 states that have prescription monitoring programs so long as provided access
5 under each such agreement is consistent with the privacy, security, and
6 disclosure protections in this chapter, and further provided that if the Vermont
7 Prescription Monitoring System contains any information regarding
8 medications prescribed for purposes of reproductive health care services or
9 gender-affirming health care services, as those terms are defined in 1 V.S.A.
10 § 150, the reciprocal agreements shall exclude those medications and any
11 information about their prescribers, dispensers, and recipients from the
12 information to be disclosed to another state’s prescription monitoring program.
13 Sec. 3. EFFECTIVE DATE
14    This act shall take effect on July 1, 2026.
                                                                   VT LEG #386242 v.1